Document Detail


A novel, automated method of temperature cycling to produce cryoprecipitate.
MedLine Citation:
PMID:  11239228     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Cryoprecipitate continues to find wide application in transfusion practice. Current AABB standards call for a minimum of 80 units (U) of factor VIII and 150 mg of fibrinogen per bag of cryoprecipitate. However, individual cryoprecipitates can vary greatly in content, with as many as 20 different factors known to affect the yield. STUDY DESIGN AND METHODS: Plasma was processed in a new, rapid, automated device (CryoSeal, Thermogenesis) with computer-controlled temperature cycling to produce cryoprecipitate. RESULTS: In repeat runs (n = 20), the automated procedure yielded a product containing 184 mg of fibrinogen and 158 U of factor VIII in 55 minutes. Additional studies using plasma pools to compare the quality of the machine-generated products to those of traditionally prepared cryoprecipitate showed comparative recoveries of 182 and 187 mg of fibrinogen and 172.1 and 129.7 U of factor VIII and no significant difference in the levels of plasminogen, protein C, or protein S. CONCLUSION: The new system offers an automated method of cryoprecipitate production in which the steps involved in temperature cycling are initiated sequentially, producing within 1 hour a preparation that is equivalent to standard cryoprecipitate.
Authors:
G Rock; R Berger; J Lange; M Tokessy; D S Palmer; A Giulivi
Related Documents :
15197728 - Chromosome translocation induced by the insertion of the ura blaster into the major rep...
9192848 - A novel tandem repeat sequence located on human chromosome 4p: isolation and characteri...
20457068 - Withdrawn: development and characterization of two mini-x chromosomal short tandem repe...
8404068 - Localization of the highly polymorphic locus d19s120 to 19p13.3 by linkage.
20148908 - Influence of parental origin of the x chromosome on physical phenotypes and gh responsi...
20499078 - Centromere inactivation and epigenetic modifications of a plant chromosome with three f...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transfusion     Volume:  41     ISSN:  0041-1132     ISO Abbreviation:  Transfusion     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-03-12     Completed Date:  2001-04-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  232-5     Citation Subset:  IM    
Affiliation:
Ottawa Hospital-Civic Campus and the Canadian Red Cross, Ottawa, Ontario, Canada. grock@ottawahospital.on.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cryopreservation / instrumentation,  methods*
Factor VIII* / chemistry
Fibrinogen* / chemistry
Humans
Plasmapheresis / methods
Reproducibility of Results
Chemical
Reg. No./Substance:
0/cryoprecipitate coagulum; 9001-27-8/Factor VIII; 9001-32-5/Fibrinogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of three Hb-based oxygen-carrying solutions on neutrophil activation in vitro: quantitative ...
Next Document:  Effect of gamma radiation on the in vitro aggregability of WBC-reduced apheresis platelets.